Profil
Herbert Raymond Henney worked as a Senior Director-Medical Affairs at Savient Pharmaceuticals, Inc. and as a Vice President-Clinical & Regulatory Affairs at W World Corp.
He also worked at Acorda Therapeutics, Inc. as a Vice President-Clinical Development from 2011 to 2014.
Henney holds a doctorate degree from the Medical University of South Carolina and an undergraduate degree from Temple University (Pennsylvania).
Anciens postes connus de Herbert Raymond Henney
| Sociétés | Poste | Fin |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2014 |
| SAVIENT PHARMACEUTICALS INC | Directeur Technique/Scientifique/R&D | - |
| W WORL | Directeur Technique/Scientifique/R&D | - |
Formation de Herbert Raymond Henney
| Temple University (Pennsylvania) | Undergraduate Degree |
| Medical University of South Carolina | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ACORDA THERAPEUTICS, INC. | Health Technology |
| W WORL | Health Technology |
| Entreprise privées | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |